2025 annual financial data
Entrada Therapeutics 2025 Operating margin
Direct answer
Operating margin was -613.66%.
Operating income was -155,998,000 USD and net income was -143,750,000 USD.
Operating cash flow was -128,512,000 USD.
Get free Entrada Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 25,421,000 USD
- Operating income
- -155,998,000 USD
- Net income
- -143,750,000 USD
- Operating cash flow
- -128,512,000 USD